 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2018 |
$92.89 |
$93.49 |
$92.31 |
$92.60 |
3.92M | | 04/17/2018 |
$93.20 |
$94.01 |
$92.62 |
$93.59 |
4.47M | | 04/18/2018 |
$94.00 |
$94.60 |
$93.02 |
$94.32 |
5.29M | | 04/19/2018 |
$94.43 |
$94.53 |
$91.40 |
$93.01 |
4.97M | | 04/20/2018 |
$93.41 |
$93.80 |
$92.02 |
$92.60 |
4.68M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. |
|
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on April 16, 2018, ABBV opened at $92.89, traded as high as $93.49 and as low as $92.31, and closed at $92.60. Trading volume was a total of 3.92M shares. On April 17, 2018, ABBV opened at $93.20, traded as high as $94.01 and as low as $92.62, and closed at $93.59. Trading volume was a total of 4.47M shares. On April 18, 2018, ABBV opened at $94.00, traded as high as $94.60 and as low as $93.02, and closed at $94.32. Trading volume was a total of 5.29M shares. On April 19, 2018, ABBV opened at $94.43, traded as high as $94.53 and as low as $91.40, and closed at $93.01. Trading volume was a total of 4.97M shares. On April 20, 2018, ABBV opened at $93.41, traded as high as $93.80 and as low as $92.02, and closed at $92.60. Trading volume was a total of 4.68M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
04/20/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$92.60 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
346.43 |
|
| Dividends reinvested/share: |
$11.79 |
|
| Total return: |
220.80% |
|
| Average Annual Total Return: |
24.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$32,079.10 |
|
| Years: |
5.30 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
04/20/2018 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$92.60 |
|
| Dividends collected/share: |
$11.79 |
|
| Total return: |
197.24% |
|
| Average Annual Total Return: |
22.84% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29,725.82 |
|
| Years: |
5.30 |
|
|
|
| Date |
Close |
| 04/16/2018 | $92.60 | | 04/17/2018 | $93.59 | | 04/18/2018 | $94.32 | | 04/19/2018 | $93.01 | | 04/20/2018 | $92.60 |
|
|
